MIP-T3 inhibitors belong to a specific chemical class that targets the catalytic activity of the enzyme MIP-T3. MIP-T3, or Mitotic Interactor and Phosphatase Regulator 3, is a key regulator of cell cycle progression, playing a crucial role in mitosis and cellular division. The inhibitors designed for MIP-T3 act by specifically binding to the active site of the enzyme, impeding its catalytic function. The active site of MIP-T3 is essential for its phosphatase activity, which is vital for the accurate progression of cell division. By obstructing this enzymatic function, MIP-T3 inhibitors exert a modulatory influence on cell cycle dynamics.
MIP-T3 inhibitors exhibit a unique configuration, often characterized by distinct molecular scaffolds that enable selective interaction with the catalytic domain of MIP-T3. The design of these inhibitors involves a meticulous consideration of the enzyme's three-dimensional structure to ensure specificity and efficacy. The binding affinity of MIP-T3 inhibitors to the active site is a critical determinant of their pharmacological activity. Researchers employ various structural biology and computational modeling techniques to optimize the chemical structure of these inhibitors, aiming to enhance their potency and selectivity. The development of MIP-T3 inhibitors represents a significant area of research within the broader field of cell cycle regulation, with implications for understanding fundamental cellular processes and potentially offering insights into new avenues for modulation of cellular functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Blocks epithelial sodium channels, which may indirectly affect MIP-T3 by altering ionic balance and membrane potential that can influence its activity. | ||||||
Benzamil•HCl | 161804-20-2 | sc-201070 | 50 mg | $195.00 | 1 | |
Inhibits epithelial sodium channels, similarly to Amiloride, potentially altering conditions that could influence MIP-T3 function. | ||||||
Triamterene | 396-01-0 | sc-213103A sc-213103 | 1 g 5 g | $22.00 $54.00 | ||
A potassium-sparing diuretic that affects ion transport and could indirectly modulate the activity of proteins such as MIP-T3. | ||||||
Hydrochlorothiazide | 58-93-5 | sc-207738 sc-207738A sc-207738B sc-207738C sc-207738D | 5 g 25 g 50 g 100 g 250 g | $55.00 $240.00 $333.00 $562.00 $988.00 | ||
A thiazide diuretic that affects electrolyte reabsorption which could have an indirect impact on MIP-T3 by altering cellular ionic environment. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
An aldosterone antagonist that influences sodium reabsorption, potentially affecting proteins like MIP-T3 indirectly. | ||||||
Eplerenone | 107724-20-9 | sc-203943 sc-203943A | 10 mg 50 mg | $110.00 $624.00 | 4 | |
An aldosterone receptor antagonist with effects similar to spironolactone, could alter MIP-T3 activity indirectly through ionic homeostasis. | ||||||
Quinine | 130-95-0 | sc-212616 sc-212616A sc-212616B sc-212616C sc-212616D | 1 g 5 g 10 g 25 g 50 g | $79.00 $104.00 $166.00 $354.00 $572.00 | 1 | |
An alkaloid that affects ion channels, which may indirectly influence MIP-T3's function by modifying the ionic balance within cells. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Similar to verapamil, this calcium channel blocker could have an indirect influence on MIP-T3 by modulating intracellular calcium. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Another calcium channel blocker that can alter calcium homeostasis in cells, potentially affecting the function of MIP-T3 indirectly. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
An inhibitor of the Na+/K+ ATPase pump, this compound could affect the ionic balance and indirectly modify the activity or expression of MIP-T3. | ||||||